SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 222 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $266 | -6.3% | 9,648 | +2.1% | 0.00% | 0.0% |
| Q2 2023 | $284 | -11.8% | 9,451 | +6.2% | 0.00% | 0.0% |
| Q1 2023 | $322 | +3.9% | 8,901 | +2.3% | 0.00% | 0.0% |
| Q4 2022 | $310 | -99.9% | 8,701 | -14.9% | 0.00% | 0.0% |
| Q3 2022 | $345,000 | +12.7% | 10,219 | -3.6% | 0.00% | 0.0% |
| Q2 2022 | $306,000 | -8.9% | 10,604 | +1.7% | 0.00% | 0.0% |
| Q1 2022 | $336,000 | +7.7% | 10,423 | -2.7% | 0.00% | 0.0% |
| Q4 2021 | $312,000 | +3.0% | 10,709 | -5.9% | 0.00% | 0.0% |
| Q3 2021 | $303,000 | -1.0% | 11,380 | +14.5% | 0.00% | 0.0% |
| Q2 2021 | $306,000 | +22.4% | 9,940 | +3.8% | 0.00% | 0.0% |
| Q1 2021 | $250,000 | +4.2% | 9,578 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $240,000 | – | 9,578 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |